Trinity Biotech plc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Trinity Biotech plc now
Current reporting with the operating signal separated from the noise.
Trinity Biotech plc: Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: official volume, pricing, inventory and segment margin.Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Trinity Biotech plc: Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Trinity Biotech plc Receives Nasdaq Compliance Notice Regarding Bid Price and Market Value Requirements
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Trinity Biotech plc Secures Additional Liquidity Through Amended Agreements with Perceptive Advisors to Support Comprehensive Transformation Plan
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)
Investors are testing whether Trinity Biotech plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q1 2022 Results
The story matters when it changes Trinity Biotech plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest TRIB filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Trinity Biotech plc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →